Showing results (21-30 of 47) with videos related to

Sort By:
Pageof 5
Expert Review of Neurotherapeutics|October 3, 2006
Bupropion: pharmacology and therapeutic applicationsKevin F Foley, Kevin P DeSanty, Richard E Kast
Bioorganic & Medicinal Chemistry|March 17, 2004
Synthesis and biological evaluation of 2-(4-fluorophenoxy)-2-phenyl-ethyl piperazines as serotonin-selective reuptake inhibitors with a potentially improved adverse reaction profileJames M Dorsey, Maria G Miranda, Nicholas V Cozzi, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|December 16, 2006
IFN-gamma and TNF-alpha decrease serotonin transporter function and expression in Caco2 cellsKevin F Foley, Cristen Pantano, Allison Ciolino, et al.
Journal of Cardiovascular Pharmacology|April 12, 2005
Inhibition of cGMP-dependent protein kinase reverses phenotypic modulation of vascular smooth muscle cellsNupur B Dey, Kevin F Foley, Thomas M Lincoln, et al.
Clinical Biochemistry|January 1, 2015
Analytical sensitivity of four commonly used hCG point of care devicesSandy M Kamer, Kevin F Foley, Robert L Schmidt, et al.
Analytical Chemistry|July 1, 2005
Intelligent signal processing for detection system optimizationChi Yung Fu, Loren I Petrich, Paul F Daley, et al.
Science (New York, N.Y.)|February 14, 2009
The hallucinogen N,N-dimethyltryptamine (DMT) is an endogenous sigma-1 receptor regulatorDominique Fontanilla, Molly Johannessen, Abdol R Hajipour, et al.
Nuclear Medicine and Biology|January 12, 2013
Radiotracers for cardiac sympathetic innervation: transport kinetics and binding affinities for the human norepinephrine transporterDavid M Raffel, Wei Chen, Yong-Woon Jung, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|June 6, 2022
Exploratory study of the dose-related safety, tolerability, and efficacy of dimethyltryptamine (DMT) in healthy volunteers and major depressive disorderDeepak Cyril D'Souza, Shariful A Syed, L Taylor Flynn, et al.
Acta Crystallographica. Section C, Structural Chemistry|January 4, 2022
Psilocybin: crystal structure solutions enable phase analysis of prior art and recently patented examplesAlexander M Sherwood, Robert B Kargbo, Kristi W Kaylo, et al.
Pageof 5